Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | polo-like kinase 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.4302 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.4302 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0971 | 0.2021 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0114 | 0.4302 | 1 |
Echinococcus multilocularis | musashi | 0.0029 | 0.0643 | 0.1495 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.4302 | 1 |
Trypanosoma brucei | polo-like protein kinase | 0.0114 | 0.4302 | 1 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.1059 | 0.2233 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1059 | 0.2463 |
Schistosoma mansoni | kinase | 0.0058 | 0.1891 | 0.4226 |
Schistosoma mansoni | intermediate filament proteins | 0.0029 | 0.0643 | 0.1236 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0039 | 0.1059 | 0.2345 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1059 | 0.2463 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0127 | 0.0296 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0127 | 0.0296 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.1059 | 0.2345 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0971 | 0.2256 |
Brugia malayi | serine/threonine-protein kinase plk-2 | 0.0114 | 0.4302 | 1 |
Leishmania major | protein kinase, putative,polo-like protein kinase, putative | 0.0114 | 0.4302 | 1 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0039 | 0.1059 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0053 | 0.1697 | 0.3852 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1059 | 0.2463 |
Loa Loa (eye worm) | PLK/PLK1 protein kinase | 0.0114 | 0.4302 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1059 | 0.2463 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1059 | 0.2463 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.4302 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0056 | 0.1827 | 0.2366 |
Toxoplasma gondii | ABC1 family protein | 0.0039 | 0.1059 | 0.5 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0039 | 0.1059 | 0.5 |
Mycobacterium ulcerans | lipase LipD | 0.0039 | 0.1059 | 0.5 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.4302 | 1 |
Echinococcus granulosus | lamin | 0.0029 | 0.0643 | 0.1495 |
Echinococcus multilocularis | lamin | 0.0029 | 0.0643 | 0.1495 |
Loa Loa (eye worm) | intermediate filament protein | 0.0029 | 0.0643 | 0.1495 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0053 | 0.1697 | 0.3852 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0056 | 0.1827 | 0.2366 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.4302 | 1 |
Trichomonas vaginalis | CAMK family protein kinase | 0.0114 | 0.4302 | 1 |
Onchocerca volvulus | Serine\/threonine kinase homolog | 0.0114 | 0.4302 | 1 |
Brugia malayi | intermediate filament protein | 0.0029 | 0.0643 | 0.1362 |
Loa Loa (eye worm) | hypothetical protein | 0.0017 | 0.0127 | 0.0296 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0017 | 0.0127 | 0.0144 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0017 | 0.0127 | 0.0296 |
Loa Loa (eye worm) | hypothetical protein | 0.0039 | 0.1059 | 0.2463 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0017 | 0.0127 | 0.0296 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0053 | 0.1697 | 0.3946 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0017 | 0.0127 | 0.0296 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0039 | 0.1059 | 0.2463 |
Echinococcus multilocularis | GPCR, family 2 | 0.0017 | 0.0127 | 0.0296 |
Loa Loa (eye worm) | hypothetical protein | 0.0028 | 0.062 | 0.1442 |
Mycobacterium leprae | conserved hypothetical protein | 0.0039 | 0.1059 | 0.5 |
Echinococcus granulosus | intermediate filament protein | 0.0029 | 0.0643 | 0.1495 |
Schistosoma mansoni | lamin | 0.0029 | 0.0643 | 0.1236 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.0971 | 0.2136 |
Onchocerca volvulus | 0.0039 | 0.1059 | 0.1138 | |
Schistosoma mansoni | lamin | 0.0029 | 0.0643 | 0.1236 |
Giardia lamblia | Kinase, PLK | 0.0114 | 0.4302 | 0.5 |
Onchocerca volvulus | 0.0039 | 0.1059 | 0.1138 | |
Echinococcus granulosus | lamin dm0 | 0.0029 | 0.0643 | 0.1495 |
Loa Loa (eye worm) | intermediate filament tail domain-containing protein | 0.0029 | 0.0643 | 0.1495 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.4302 | 1 |
Onchocerca volvulus | 0.0039 | 0.1059 | 0.1138 | |
Entamoeba histolytica | serine/threonine protein kinase, putative | 0.0114 | 0.4302 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0039 | 0.1059 | 0.2233 |
Brugia malayi | Intermediate filament tail domain containing protein | 0.0029 | 0.0643 | 0.1362 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0017 | 0.0127 | 0.0144 |
Mycobacterium ulcerans | beta-lactamase | 0.0039 | 0.1059 | 0.5 |
Loa Loa (eye worm) | beta-lactamase | 0.0039 | 0.1059 | 0.2463 |
Loa Loa (eye worm) | cytoplasmic intermediate filament protein | 0.0015 | 0.0066 | 0.0153 |
Plasmodium vivax | hypothetical protein, conserved | 0.0039 | 0.1059 | 0.5 |
Echinococcus granulosus | serine:threonine protein kinase PLK1 | 0.0114 | 0.4302 | 1 |
Mycobacterium leprae | Probable lipase LipE | 0.0039 | 0.1059 | 0.5 |
Brugia malayi | beta-lactamase | 0.0039 | 0.1059 | 0.2345 |
Loa Loa (eye worm) | hypothetical protein | 0.0029 | 0.0643 | 0.1495 |
Brugia malayi | beta-lactamase family protein | 0.0039 | 0.1059 | 0.2345 |
Loa Loa (eye worm) | hypothetical protein | 0.0053 | 0.1697 | 0.3946 |
Trypanosoma cruzi | polo-like protein kinase, putative | 0.0114 | 0.4302 | 1 |
Echinococcus multilocularis | lamin dm0 | 0.0029 | 0.0643 | 0.1495 |
Mycobacterium ulcerans | hypothetical protein | 0.0039 | 0.1059 | 0.5 |
Echinococcus granulosus | GPCR family 2 | 0.0017 | 0.0127 | 0.0296 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0039 | 0.1059 | 0.2463 |
Echinococcus multilocularis | serine:threonine protein kinase PLK1 | 0.0114 | 0.4302 | 1 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0039 | 0.1059 | 0.2463 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 13.3714 uM | PubChem BioAssay. qHTS for Inhibitors of PLK1-PDB (polo-like kinase 1 - polo-box domain): Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PUBCHEM_BIOASSAY: Inhibitors of the vitamin D receptor (VDR): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504855] | ChEMBL. | No reference |
Potency (functional) | 39.8107 uM | PubChem BioAssay. qHTS Assay for Activators of ClpP. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 50.1187 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Mammalian Selenoprotein Thioredoxin Reductase 1 (TrxR1): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488771] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.